Size and Charge Characterization of Lipid Nanoparticles for mRNA Vaccines - Archive ouverte HAL
Article Dans Une Revue Analytical Chemistry Année : 2022

Size and Charge Characterization of Lipid Nanoparticles for mRNA Vaccines

Résumé

Messenger RNA vaccines have come into the spotlight as a promising and adaptive alternative to conventional vaccine approaches. The efficacy of mRNA vaccines relies on the ability of mRNA to reach the cytoplasm of cells, where it can be translated into proteins of interest allowing to trigger the immune response. However, unprotected mRNA is unstable, susceptible to degradation by exo and endonucleases, and its negative charges are electrostatically repulsed by the anionic cell membranes. Therefore, mRNA needs a delivery system that protects the nucleic acid from degradation and allows it to enter into the cells. Lipid nanoparticles (LNPs) represent the non-viral leading vector for mRNA delivery. Physicochemical parameters of LNPs, including their size and their charge, directly impact their in vivo behavior and, therefore, their cellular internalization. In this work, Taylor Dispersion Analysis (TDA) was used as a new methodology for the characterization of the size and polydispersity of LNPs, and capillary electrophoresis (CE) was used for the determination of LNPs global charge. The results obtained were compared with those obtained by dynamic light scattering (DLS) and Laser Doppler Electrophoresis (LDE).
Fichier principal
Vignette du fichier
Manuscript File_LNP1_Formulaction.pdf (1.23 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03732053 , version 1 (21-07-2022)

Identifiants

Citer

Camille Malburet, Laurent Leclercq, Jean-François Cotte, Jérôme Thiebaud, Emilie Bazin, et al.. Size and Charge Characterization of Lipid Nanoparticles for mRNA Vaccines. Analytical Chemistry, 2022, 94 (11), pp.4677-4685. ⟨10.1021/acs.analchem.1c04778⟩. ⟨hal-03732053⟩
191 Consultations
1195 Téléchargements

Altmetric

Partager

More